Analysis of the chemotherapy drug 5-fluorouracil and its metabolites by surface-enhanced Raman spectroscopy

被引:4
作者
Gift, AD [1 ]
Shende, C [1 ]
Inscore, FE [1 ]
Farquharson, S [1 ]
机构
[1] Real Time Analyzers, E Hartford, CT 06108 USA
来源
SMART MEDICAL AND BIOMEDICAL SENSOR TECHNOLOGY II | 2004年 / 5588卷
关键词
chemotherapy; 5-fluorouracil; trace chemical analysis; SERS; Raman spectroscopy; sol-gel;
D O I
10.1117/12.579353
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Chemotherapy drug dosage is based on the limited statistics of the response of previously treated patients and administered according to body surface area. Considerably better dose regulation could be performed if the drug metabolism of each patient could be monitored. Unfortunately, current technologies require multiple withdrawals of blood to determine metabolism, a precious fluid in limited supply. Saliva analysis has long been considered an attractive alternative, but unfortunately standard techniques require large quantities that are difficult to obtain. In an effort to overcome this limitation we have been investigating the ability of metal-doped sol-gels to both separate drugs and their metabolites from saliva and generate surface-enhanced Raman spectra. Surface-enhanced Raman spectroscopy has the potential to perform this analysis with just a few drops of sample due to its extreme sensitivity. Preliminary measurements are presented for the chemotherapy drug, 5-fluorouracil, and its two metabolites 5-fluorouridine and 5-fluoro-2'-deoxyuridine, and the potential of determining metabolism on a patient-by-patient basis.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 35 条
[1]   O6-alkylguanine-DNA alkyltransferase:: influence on susceptibility to the genetic effects of alkylating agents [J].
Kyrtopoulos, SA .
TOXICOLOGY LETTERS, 1998, 103 :53-57
[2]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[3]   Pharmacokinetics of cyclophosphamide (CP) and 4-OH-CP/aldophosphamide in systemic vasculitis [J].
Belfayol-Pisanté, L ;
Guillevin, L ;
Tod, M ;
Fauvelle, F .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2000, 14 (04) :415-421
[4]   Raman and SERS microspectroscopy on living cells: a promising tool towards cellular-drug response and medical diagnosis [J].
Beljebbar, A ;
Sockalingum, GD ;
Morjani, H ;
Manfait, M .
BIOMEDICAL APPLICATIONS OF RAMAN SPECTROSCOPY, PROCEEDINGS OF, 1999, 3608 :175-184
[5]  
Carmona P, 1999, J RAMAN SPECTROSC, V30, P631, DOI 10.1002/(SICI)1097-4555(199908)30:8<631::AID-JRS404>3.0.CO
[6]  
2-N
[7]  
CASALE F, IN PRESS PHARM RES
[8]  
Chamberlain J., 1995, ANAL DRUGS BIOL FLUI
[9]   Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and saliva [J].
de Jonge, MJA ;
Verweij, J ;
Loos, WJ ;
Dallaire, BK ;
Sparreboom, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (05) :491-499
[10]   FAMILIAL DEFICIENCY OF DIHYDROPYRIMIDINE DEHYDROGENASE - BIOCHEMICAL BASIS FOR FAMILIAL PYRIMIDINEMIA AND SEVERE 5-FLUOROURACIL-INDUCED TOXICITY [J].
DIASIO, RB ;
BEAVERS, TL ;
CARPENTER, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (01) :47-51